The assembly and activation of kinin-forming systems on the surface of human U-937 macrophage-like cells

Biological Chemistry

Volumn 390, Issue 3, 2009, Pages 269-275

  Barbasz, Anna ^a   Kozik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Bradykinin; Contact system; Factor XII; Monocytes; Plasma prekallikrein

Indexed keywords

BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 12A; CD11B ANTIGEN; KININ; KININOGEN; PREKALLIKREIN; TISSUE KALLIKREIN;

ADSORPTION; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL STRAIN U937; CELL SURFACE; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN SECRETION;

FACTOR XII; HUMANS; KININOGENS; KININS; MACROPHAGES; PREKALLIKREIN; U937 CELLS;

EID: 62249183099     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.032     Document Type: Article

References (48)

1. Asakura, S., Hurley, R.W., Skorstengaard, K., Ohkubo, I., and Mosher, D. (1992). Inhibition of cell adhesion by high molecular weight kininogen. J. Cell Biol. 116, 465-476.
2. Barbasz, A., Guevara-Lora, I., Rapała-Kozik, M., and Kozik, A. (2008). Kininogen binding to the surface of macrophages. Int. Immunopharmacol. 8, 211-216.
3. Bengtson, S.H., Sanden, C., Mörgelin, M., Marx, P.F., Olin, A.I., Leeb-Lundberg, L.M.F., Meijers, J.C.M., and Herwald, H. (2009). Activation of TAFI on the surface of Streptococcus pyogenes evokes inflammatory reactions by modulating the kallikrein/kinin system. J. Innate Immun. 1, 18-28.
4. Bhoola, K.D., Figueroa, C.D., and Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharm. Rev. 44, 1-80.
5. Böckmann, S. and Paegelow, I. (2000). Kinins and kinin receptors: importance for the activation of leukocytes. J. Leukoc. Biol. 68, 587-592.
6. Calixto, J.B., Cabrini, A., Ferreira, J., and Campos, M.M. (2000). Kinins in pain and inflammation. Pain 87, 1-5.
7. Colman, R.W. (1994). Structure-function correlates of human high molecular weight kininogen. Braz. J. Med. Biol. Res. 27, 1839-1853.
8. Colman, R.W. and Schmaier, A.H. (1997). Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 90, 3819-3843.
9. Duliński, R., Suder, P., Guevara-Lora, I., Rapala-Kozik, M., Potempa, J., Silberring, J., Imamura, T., Travis, J., and Kozik, A. (2003). Attenuated kinin release from human neutrophil elastase-pretreated kininogens by tissue and plasma kallikreins. Biol. Chem. 384, 929-937.
10. Ellis, V., Scully, M.F., and Kakkar, V.V. (1989). Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J. Biol. Chem. 264, 2185-2188.
11. Figueroa, C.D., MacIver, A.G., and Bhoola, K.D. (1989). Identification of a tissue kallikrein in human polymorphonuclear leucocytes. Br. J. Haematol. 72, 321-328.
12. Gustafson, E.J., Schutsky, D., Knight, L.C., and Schmaier, A.H. (1986). High molecular weight kininogen binds to unstimulated platelets. J. Clin. Invest. 78, 310-318.
13. Gustafson, E.J., Schmaier, A.H., Wachtfogel, Y.T., Kaufman, N., Kucich, U., and Colman, R.W. (1989). Human neutrophils contain and bind high molecular weight kininogen. J. Clin. Invest. 84, 28-35.
14. Harris, P. and Ralph, P. (1985). Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J. Leukoc. Biol. 37, 407-422.
15. Henderson, L.M., Figueroa, C.D., Muller-Esterl, W., Stain, A., and Bhoola, K.D. (1992). Immunovisualisation of plasma prekallikrein and H-kininogen on human neutrophils and in human hepatocytes. Agents Actions (Suppl.) 38, 590-594.
16. Henderson, L., Figueroa, C.D., Müller-Esterl, W., and Bhoola, K.D. (1994). Assembly of contact-phase factors on the surface of the human neutrophil membrane. Blood 84, 474-482.
17. Imamura, T., Pike, R.N., Potempa, J., and Travis, J. (1994). Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J. Clin. Invest. 94, 361-367.
18. Imamura, T., Dubin, A., Moore, W., Tanaka, R., and Travis, J. (1996). Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Lab. Invest. 74, 861-870.
19. Imamura, T., Tanase, S., Hayashi, I., Potempa, J., Kozik, A., and Travis, J. (2002). Release of a new vascular permeability enhancing peptide from kininogens by human neutrophil elastase. Biochem. Biophys. Res. Commun. 294, 423-428.
20. Imamura, T., Potempa, J., and Travis, J. (2004). Activation of the kallikrein-kinin system and release of new kinins through alternative cleavage of kininogens by microbial and human cell proteinases. Biol. Chem. 385, 989-996.
21. Joseph, K. and Kaplan, A.P. (2005). Formation of bradykinin: a major contribution to the innate inflammatory response. Adv. Immunol. 86, 159-208.
22. Joseph, K., Ghebrehiwet, B., and Kaplan, A.P. (2001). Activation of the kinin-forming cascade on the surface of endothelial cells. Biol. Chem. 382, 71-75.
23. Joseph, K., Tholanikunnel, B.G., and Kaplan, A.P. (2002). Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII. Proc. Natl. Acad. Sci. USA 99, 896-900.
24. Kaplan, A.P., Kay, A.B., and Austen, K.F. (1972). A prealbumin activator of prekallikrein. III. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J. Exp. Med. 135, 81-97.
25. Kaplan, A.P., Joseph, K., and Silverberg, M. (2002). Pathways for bradykinin formation and inflammatory disease. J. Allergy Clin. Immunol. 109, 195-209.
26. Kemme, M., Podlich, D., Raidoo, D.M., Snyman, C., Naidoo, S, and Bhoola, K.D. (1999). Identification of immunoreactive tissue prekallikrein on the surface membrane of human neutrophils. Biol. Chem. 380, 1321-1328.
27. Khan, M.M., Bradford, H.N., Isordia-Salas, I., Liu, Y., Wu, Y., Espinola, R.G., Ghebrehiwet, B., and Colman, R.W. (2006). High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1, and gC1qR in monocytes. Arterioscler. Thromb. Vasc. Biol. 26, 2260-2266.
28. Kozik, A., Moore, R.B., Potempa, J., Imamura, T., Rapala-Kozik, M., and Travis, J. (1998). A novel mechanism for bradykinin production at inflammatory sites. Diverse effect of a mixture of neutrophil elastase and mast cell tryptase versus tissue and plasma kallikreins on native and oxidized kininogens. J. Biol. Chem. 273, 33224-33229.
29. Luster, A.D., Alon, R., and von Andrian, U.H. (2005). Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6, 1182-1190.
30. Mahdi, F., Madar, Z.S., Figueroa, C.D., and Schmaier, A.H. (2002). Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes. Blood 99, 3585-3596.
31. Molla, A., Yamamoto, T., Akaike, T., Miyoshi, S., and Maeda, H. (1989). Activation of Hageman factor and prekallikrein and generation of kinin by various microbial proteinases. J. Biol. Chem. 264, 10589-10594.
32. Motta, G., Røjkjær, R., Hasan, A.A., Cines, D.B., and Schmaier, A.H. (1998). High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation. Blood 91, 690-697.
33. Munson, P.J. and Rodbard, D. (1980). LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107, 220-239.
34. p, the C1q receptor that enhances phagocytosis, is detected specifically in human cells of myeloid lineage, endothelial cells, and platelets. J. Immun. 160, 1929-1935.
35. Paegelow, I., Werner, H., and Reibmann, S. (1995). Effects of bradykinin and bradykinin analogues on spleen cells of mice. Eur. J. Pharmacol. 279, 211-216.
36. Raab, A. and Kemme, M. (2000). High-molecular-weight kininogen is a binding protein for tissue prokallikrein. FEBS Lett. 467, 165-168.
37. Rajasekariah, P., Warlow, R.S., and Walls, R.S. (1997). High affinity bradykinin binding to human inflammatory cells. Biochem. Mol. Biol. Int. 43, 279-290.
38. Ralph, P., Moore, M.A., and Nilsson, K. (1976). Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J. Exp. Med. 143, 1528-1533.
39. Reddigari, S.R., Shibayama, Y., Brunnee, T., and Kaplan, A.P. (1993). Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. J. Biol. Chem. 268, 11982-11987.
40. Rehli, M., Krause, S.W., Kreutz, M., and Andreesen, R. (1995). Carboxypeptidase M is identical to the MAX.1 antigen and its expression is associated with monocyte to macrophage differentiation. J. Biol. Chem. 270, 15644-15649.
41. Røjkjær, R., Hasan, A.A., Motta, G., Schousboe, I., and Schmaier, A.H. (1998). Factor XII does not initiate prekallikrein activation on endothelial cells. Thromb. Haemost. 80, 74-81.
42. 3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and increase in cyclin expression. Blood 93, 2721-2729.
43. Sato, E., Koyama, S., Nomura, H., Kubo, K., and Sekiguchi, M. (1996). Bradykinin stimulates alveolar macrophages to release neutrophil, monocyte, and eosinophil chemotactic activity. J. Immunol. 157, 3122-3129.
44. Shariat-Madar, Z., Mahdi, F., and Schmaier, A.H. (2002). Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J. Biol. Chem. 277, 17962-17969.
45. Springer, T.A. (1994). Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301-314.
46. Stuardo, M., Gonzalez, C.B., Nualart, F., Boric, M., Corthorn, J., Bhoola, K.D., and Figueroa, C.D. (2004). Stimulated human neutrophils form biologically active kinin peptides from high and low molecular weight kininogens. J. Leukoc. Biol. 75, 631-640.
47. Tiffany, C.W. and Burch, R.W. (1989). Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages. FEBS Lett. 247, 189-192.
48. Toossi, Z., Sedor, J.R., Mettler, M.A., Everson, B., Young, T., and Ratnoff, O.D. (1992). Induction of expression of monocyte interleukin 1 by Hageman factor (factor XII). Proc. Natl. Acad. Sci. USA 89, 11969-11972.